LASER Assisted New Attachment Procedure, Excisional New Attachment Procedure and Subgingival curettage in the treatment of chronic periodontitis

Evaluation of LANAP,ENAP and Subgingival curettage in the treatment of chronic periodontitis -A Split mouth Clinical Study - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057472

Enrollment

Registered

2023-09-12

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: LANAP, ENAP and Subgingival curettage.: In all patients extra oral antisepsis and intra oral antisepsis will be performed with 5% povidone iodine solution and 0.2% chlorhexidine digluco

Eligibility

Inclusion criteria

Inclusion criteria: 1- Patient diagnosed with chronic periodontitis. 2- Age between 35-60 years. 3- Teeth selection: All the teeth diagnosed with chronic periodontitis on clinical and radiographic evaluation. 4- The sites should exhibit clinical evidence of probing pocket depth of = 5mm and clinical attachment loss = 3mm. 5- Systemically healthy patients. 6- Patients with established willingness and ability to perform adequate oral hygiene

Exclusion criteria

Exclusion criteria: 1- Subjects who have received periodontal flap/regenerative therapy within the past 1 year 2- Patients who have received antibiotic therapy within the past six months 3- Pregnant and lactating patients 4- Smokers and tobacco chewers 5- Patients who demonstrate poor oral hygiene maintenance after Phase I therapy 6- Tooth with gingival recession and endodontic-pulpal involvement. 7- Systemic illness known to affect the outcomes of periodontal therapy; such as uncontrolled diabetes mellitus, cardiac diseases, immune-compromised (e.g., HIV individuals, under radiotherapy), patients taking medications such as corticosteroids or calcium channel blockers, which are known to interfere with periodontal wound healing 8- Patients with any known allergy to drugs

Design outcomes

Primary

Measure	Time frame
The possible outcome of this study will be to see reduction in Probing depth and improvement in Clinical attachment level with ENAP and LANAP in chronic periodontitis casesTimepoint: Baseline 1 Month 3 Months	—

Secondary

Measure	Time frame
To assess gingival inflammationTimepoint: Baseline 1 Month 3 Months	—

Countries

India

Contacts

Public ContactSweety Sonar

Sardar Patel Post Graduate Institute of Dental and Medical Sciences

dr.vinod2112@gmail.com9695910080

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026